Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2007
11/22/2007US20070270480 Biphenyl Derived Thiamides as Calpain Inhibitors
11/22/2007US20070270472 Amino, Amino Acid or Peptide Conjugates of Retinoic Acid
11/22/2007US20070270422 Aromatic Compounds
11/21/2007EP1857456A1 Process for producing compound with anti-hcv potency and intermediate for use therein
11/21/2007EP1856031A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2007EP1856029A1 Crystalline acat inhibitor
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007CN101074202A Production of injecting reductive glutathione
11/21/2007CN101074194A Carboxide synthesis and synthesizer
11/21/2007CN100349905C Ligands for use in catalytic processes
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297817 Thio-substituted arylmethanesulfinyl derivatives
11/20/2007US7297803 Recovery of lutein esters from marigold oleoresin using a blend of ethanol and a propanol lower alkanols
11/15/2007WO2007129729A1 Process for production of fish-derived ceramide, and ceramide-containing composition
11/15/2007WO2007073856A3 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids
11/15/2007US20070265470 Crystallizing iopromide from mother liquor; dissolving iopromide crystals in a solvent, heat treating dissolved iopromide in a tubular flow reactor, and crystallizing iopromide which is suitable for pharmaceutical purposes and contains atropisomeric forms in a ratio 40-51% isomer 1, 49-60% isomer
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265345 Novel Biphenyl Compounds And Their Use
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265303 5-[(1R)-2-({2-[4-(4-{3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-hydroxyphenyl}butoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one; chronic obstructive pulmonary disease (COPD), allergies
11/15/2007US20070265296 Nuclear receptor binding agents
11/15/2007US20070265281 Organic Compounds and Their Uses
11/15/2007US20070265266 Active Agents Combination Exhibiting Insecticidal and Acaricide Properties
11/15/2007US20070264262 Adrenoceptor beta 2-mediated diseases such as asthma and chronic obstructive pulmonary disease (COPD); N-(4-tert-butylbenzyl)-4-{[({3-[(2R)-2-(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino)propyl]phenyl}acetyl)amino]methy} benzamide
11/15/2007US20070264217 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
11/14/2007EP1854781A1 Radioactive halogen-labeled phenyloxyaniline derivatives
11/14/2007EP1853553A1 Substituted hydroxyethylamines
11/14/2007EP1853551A1 Process and methods for the preparation of gabapentin and its intermediates
11/14/2007EP1853549A1 Selective splitting of substituted bisbenzylamides and bisbenzylamines
11/14/2007EP1853538A2 Modulator
11/14/2007EP1853353A2 Carboxylic acid amides provoking a cooling sensation
11/14/2007EP1670310B1 Capsaicin derivates and the production and use thereof
11/14/2007CN101072767A Method for preparing n-phenylpyrazole-1-carboxamides
11/14/2007CN101072761A 2-alkyl-cycloalk(en)yl-carboxamides
11/14/2007CN101072749A Method for the production of n,n-dimethylacetamide (DMAC)
11/14/2007CN101072748A Method for the production of n,n-dimethylacetamide (DMAC)
11/14/2007CN101072747A Method for producing n,n-dimethylacetamide (DMAC)
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070290A Nitro-catalytic hydrogenation method in N-(3-nitro-4-methoxyphenyl) amide
11/14/2007CN101070289A Process for extracting capsaicin crystal from dry capsium
11/14/2007CN101069501A Use of double substituted long-chain alkylamido sulfonates as crystallization inhibitor in azoles farm chemicals
11/14/2007CN100348574C Method for preparing purified capsicine of monomer
11/14/2007CN100348569C Induction of apoptosis in cancer cells
11/13/2007US7294743 Method for synthesis of acrylamide derivatives
11/13/2007US7294740 Oxidizing a N-(5-alkoxy-2-methyl-4-nitrophenyl)acetamide with potassium permanganate in solution of water and a cosolvent in the presence of magnesium sulfate
11/13/2007US7294643 UK-1 analogues: methods of preparation and use
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007CA2384322C Polyalkoxylated superamides optionally functionalised, use as emulsifiers
11/08/2007WO2007127445A2 Process for the preparation of cinacalcet base
11/08/2007WO2007126886A1 Process for preparing memantine hydrochloride substantially free of impurities
11/08/2007WO2007126362A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007WO2007125196A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007WO2007084450A3 Cannibinoid receptor modulators
11/08/2007US20070259955 Process for the Preparation of Nateglinide
11/08/2007US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
11/08/2007DE10318326B4 Verfahren zur Herstellung von Aziridinen und N-Vinylamiden A process for the production of aziridines and N-vinylamides
11/08/2007CA2650914A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007CA2650480A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007CA2649616A1 Process for the preparation of cinacalcet base
11/08/2007CA2644819A1 Process for preparing memantine hydrochloride substantially free of impurities
11/07/2007EP1359141B1 Method of friedel-crafts acylation of anilides
11/07/2007CN101068805A Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
11/07/2007CN101068773A Melanin concentrating hormone antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068771A Method for purifying polar vinyl compounds
11/07/2007CN101066933A Extraction process and product of day lily extract with rich colchicine
11/07/2007CN100347162C N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
11/07/2007CN100347151C Novel aminobenzoephenones
11/06/2007US7291752 Production method of β-amino acid
11/06/2007US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/06/2007US7291615 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/01/2007WO2007123718A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES
11/01/2007WO2007123581A1 Glucagon receptor antagonists, preparation and therapeutic uses
11/01/2007US20070254958 by preventing the formation of insoluble beta-amyloid and arresting the production of beta-amyloid; e.g. 3-{2-[(5-aminopentyl)amino]-2-oxoethoxy}-5-({[(1R)-1-(4-fluorophenyl)ethyl]amino}carbonyl)phenyl phenylmethanesulfonate
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
11/01/2007CA2629223A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/2007
10/31/2007EP1849766A1 Beta-benzyloxyaspartic acid derivative having two substituents on benzene ring
10/31/2007EP1390342B1 Substituted aromatic amide derivatives, intermediates thereof, agrohorticultural insecticide containing thereof and method for the use thereof
10/31/2007CN101065351A Carboxamides and their use
10/31/2007CN101062911A Dihydro quinone compounds and preparation method and medicinal usage thereof
10/31/2007CN101062904A Method for purifying capsicine compound from capsicol resin by using ammoniacal liquor
10/31/2007CN101062023A Selective androgen receptor modulators and methods of use thereof
10/31/2007CN100345827C Bicyclic aromatic compound
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288674 Optically active bisoxazoline compounds, process for production of the same and use thereof
10/30/2007US7288671 Perhydro- or hydrophenanthrene derivatives; antiinflammatory, analgesic, anticarcinogenic, and antitumor agents; , autoimmune, skin, cardiovascular, and viral diseases
10/30/2007US7288619 Fluorinated polyether polyamine and method of making the same
10/30/2007US7288262 Composition comprising a cyclohexane-based compound, compound and use of said compound to structure a composition
10/30/2007CA2321741C Method of particle formation
10/25/2007WO2007120083A1 The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
10/25/2007WO2007119580A1 Process for production of carboxylic acid chloride compound
10/25/2007WO2007118964A1 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
10/25/2007WO2007027582A3 Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
10/25/2007US20070249853 Colorless, photostable, broad UV-A sunscreen agent compounds based on bis(4-aminophenyl)-2-cyanoacrylates) where the amino group on the phenyl forms an amide, carbamate, or sulfonamide in the linking group; also corresponding cyanoacrylamide and 1-cyanovinylsulfones
10/25/2007US20070249816 Methods for carbon istope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/24/2007EP1846375A1 2-amino-1-phenylethylcarboxamide derivatives
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 289